Cargando…

Can the ‘Head-Turning Sign’ Be a Clinical Marker of Alzheimer's Disease?

AIMS: To investigate the incidence and severity of the ‘head-turning sign’ (HTS), i.e. turning the head back to the caregiver(s) for help, in patients with various dementias and discuss its clinical specificity in Alzheimer's disease (AD). METHODS: We investigated the incidence and severity of...

Descripción completa

Detalles Bibliográficos
Autores principales: Fukui, T., Yamazaki, T., Kinno, R.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: S. Karger AG 2011
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3246279/
https://www.ncbi.nlm.nih.gov/pubmed/22203823
http://dx.doi.org/10.1159/000332605
_version_ 1782219930143293440
author Fukui, T.
Yamazaki, T.
Kinno, R.
author_facet Fukui, T.
Yamazaki, T.
Kinno, R.
author_sort Fukui, T.
collection PubMed
description AIMS: To investigate the incidence and severity of the ‘head-turning sign’ (HTS), i.e. turning the head back to the caregiver(s) for help, in patients with various dementias and discuss its clinical specificity in Alzheimer's disease (AD). METHODS: We investigated the incidence and severity of HTS while administering a short cognitive test (the revised Hasegawa Dementia Rating Scale: HDSR) in outpatients with AD [125 patients, including 4 with AD + vascular dementia (VaD)], 8 with amnestic mild cognitive impairment (aMCI), 34 with dementia with Lewy bodies (DLB), 8 with progressive supranuclear palsy (PSP) and 6 with VaD. RESULTS: Significant differences were found among the 5 disease groups in the incidence and severity of HTS, and HDSR scores. Given the significant differences between AD and DLB in post hoc analyses, patients were dichotomized into AD-related (AD and aMCI) and AD-nonrelated (PSP, DLB and VaD) groups. Both incidence (41 vs. 17%, p = 0.002) and severity of HTS (0.80 ± 1.13 vs. 0.21 ± 0.60, p = 0.001) were significantly higher in the AD-related group, while average age and HDSR scores were comparable between both groups. AD-related disease, female gender and low HDSR score contributed significantly to the occurrence and severity of HTS. CONCLUSIONS: HTS can be a clinical marker of AD and aMCI, and may represent a type of excuse behavior as well as a sign of dependency on and trust in the caregivers.
format Online
Article
Text
id pubmed-3246279
institution National Center for Biotechnology Information
language English
publishDate 2011
publisher S. Karger AG
record_format MEDLINE/PubMed
spelling pubmed-32462792011-12-27 Can the ‘Head-Turning Sign’ Be a Clinical Marker of Alzheimer's Disease? Fukui, T. Yamazaki, T. Kinno, R. Dement Geriatr Cogn Dis Extra Original Research Article AIMS: To investigate the incidence and severity of the ‘head-turning sign’ (HTS), i.e. turning the head back to the caregiver(s) for help, in patients with various dementias and discuss its clinical specificity in Alzheimer's disease (AD). METHODS: We investigated the incidence and severity of HTS while administering a short cognitive test (the revised Hasegawa Dementia Rating Scale: HDSR) in outpatients with AD [125 patients, including 4 with AD + vascular dementia (VaD)], 8 with amnestic mild cognitive impairment (aMCI), 34 with dementia with Lewy bodies (DLB), 8 with progressive supranuclear palsy (PSP) and 6 with VaD. RESULTS: Significant differences were found among the 5 disease groups in the incidence and severity of HTS, and HDSR scores. Given the significant differences between AD and DLB in post hoc analyses, patients were dichotomized into AD-related (AD and aMCI) and AD-nonrelated (PSP, DLB and VaD) groups. Both incidence (41 vs. 17%, p = 0.002) and severity of HTS (0.80 ± 1.13 vs. 0.21 ± 0.60, p = 0.001) were significantly higher in the AD-related group, while average age and HDSR scores were comparable between both groups. AD-related disease, female gender and low HDSR score contributed significantly to the occurrence and severity of HTS. CONCLUSIONS: HTS can be a clinical marker of AD and aMCI, and may represent a type of excuse behavior as well as a sign of dependency on and trust in the caregivers. S. Karger AG 2011-10-11 /pmc/articles/PMC3246279/ /pubmed/22203823 http://dx.doi.org/10.1159/000332605 Text en Copyright © 2011 by S. Karger AG, Basel http://creativecommons.org/licenses/by-nc-nd/3.0/ This is an Open Access article distributed under the terms of the Creative Commons Attribution-Noncommercial-No-Derivative-Works License (http://creativecommons.org/licenses/by-nc-nd/3.0/). Users may download, print and share this work on the Internet for noncommercial purposes only, provided the original work is properly cited, and a link to the original work on http://www.karger.com and the terms of this license are included in any shared versions.
spellingShingle Original Research Article
Fukui, T.
Yamazaki, T.
Kinno, R.
Can the ‘Head-Turning Sign’ Be a Clinical Marker of Alzheimer's Disease?
title Can the ‘Head-Turning Sign’ Be a Clinical Marker of Alzheimer's Disease?
title_full Can the ‘Head-Turning Sign’ Be a Clinical Marker of Alzheimer's Disease?
title_fullStr Can the ‘Head-Turning Sign’ Be a Clinical Marker of Alzheimer's Disease?
title_full_unstemmed Can the ‘Head-Turning Sign’ Be a Clinical Marker of Alzheimer's Disease?
title_short Can the ‘Head-Turning Sign’ Be a Clinical Marker of Alzheimer's Disease?
title_sort can the ‘head-turning sign’ be a clinical marker of alzheimer's disease?
topic Original Research Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3246279/
https://www.ncbi.nlm.nih.gov/pubmed/22203823
http://dx.doi.org/10.1159/000332605
work_keys_str_mv AT fukuit cantheheadturningsignbeaclinicalmarkerofalzheimersdisease
AT yamazakit cantheheadturningsignbeaclinicalmarkerofalzheimersdisease
AT kinnor cantheheadturningsignbeaclinicalmarkerofalzheimersdisease